ANI Pharmaceuticals, Inc. (ANIP) Earnings Review: Are There Any Trades?

90 days have passed by since the last earnings report for ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) and the new quarterly results look set to arrive tomorrow. The shares of ANIP at the moment are trading at a volume of 0.19 million, which compares with its normal daily standard volume of 167.42 million shares. This has led to the shares of the company advancing by 1.72%, currently exchanging hands at $79.83 a share. ANIP stock has been up by $7.13 (-8.2%) ever since it reached its 52-week high of $86.96 back in July 31, 2019. It has progressed above its 50-day moving average of $74.15 and is up 1.4% over the past week. The stock has retreated -4.9% since the last one arrived so the question here is that will the downbeat trend in that time frame continue leading up to its next earnings release, or is the ANIP share price due for a breakout?

ANI Pharmaceuticals, Inc. (ANIP) Forecasts And Latest Quarter Earnings

Ahead of their fiscal third-quarter to be released on Wednesday, Nov 06, 2019, 3 analysts who are covering the company are estimating that it will record a profit of $1.43 per share, with analysts having different outlooks from $1.37 to $1.48. The current agreed outlook, when compared to the profit recorded last year, is at $1.29 a share, thus an increase of 10.85% is expected. The profit view for a complete financial year for ANI Pharmaceuticals, Inc. is expected to be around $5.73 in current year, a decline of nearly 13.02% from last year which was $5.07.

Let’s now look at their sales section, ANIP’s revenue is estimated to be $50703, a figure which is more than the $50703 recorded for Q3 last year. Their sequential sales though are expected to move versus Q2’s $54.36B. Their full-year outlook is pegged at $222.67M, implying that there would be an increase of 10.46% over the $201.58M they recorded last year in revenue. ANI Pharmaceuticals, Inc. is projected to get sales lifted by 9.68% in the next quarter, with a revenue target of $244.23M.

Analyzing The Earnings History Of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

In the past few years, the ANIP stock has been known to miss the Wall Street’s earnings projection. The company missed 33% of the time, according to the data pulled on their earnings, was able to meet predictions on 0 occasions and topped expectations 8 times. Looking at the past trend, the price of ANI Pharmaceuticals, Inc. shares had risen following the release of their earnings in 14 of the last 23 quarters.

Looking back, here is how ANI Pharmaceuticals, Inc. (ANIP) stock reacted to earnings misses and beats. It gave investors reason to be bullish with the price going down after 1 of the last four earnings reports. The shares of ANI Pharmaceuticals, Inc. recorded -12.04%, 3.06%, 5.91% and 3.76%, respectively, on the first day of past earnings releases. After a week of earnings reports, the changes were -12.73%, -2.62%, 6.6% and 1.73%. Their post-earnings price movements have resulted in an average increase of 0.17% and an average decrease of -1.76% in ANI Pharmaceuticals, Inc. on next day and 7th day, sequentially. ANIP’s one month stock performance led to its shares rising by 8.76% with a return of 53.22% witnessed over the last 52 weeks.

The higher number of analysts has assigned a buy or better ratings (3) on the ANI Pharmaceuticals, Inc. stock, while 0 of them have a rating of a Hold with the 11-year target price suggested by the analysts standing at $83.67. This price target implies potential upside of 4.81 percent over the next 12 months based on the current share price.

ANI Pharmaceuticals, Inc. (ANIP) Post Earnings Announcement Drift (PEAD)

Back on August 07, 2019, ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) released its Q2 results, in which it recorded EPS of $1.44 that exceeded consensus estimates of $1.28. After the earnings were reported, the price of ANIP stock kicked off the session at $63.73 and remained in a range of $76.53 to $76.53 on the first day. The shares were priced at $72.62 at the close with a total volume of shares being 506945.

On May 09, 2019, the Q1 earnings report was disclosed with EPS of $1.3. This was above the estimation of $1.05 per share. The stock price range of ANIP was between $73.15 and $73.5 on the first-day post announcement, after opening the day at $68.31. The session came to close at $73.17 and there was a total volume of 253597 shares.

February 27, 2019 was the day when its Q4 results were unveiled. The earnings came in at $1.32, beating the projected $1.24 per share. The very next day, ANIP stock opened at $60.49 while staying in a range of $64.58 to $65. At the end, it moved to $64.71 a total volume of shares been 179542.

In the year-ago Q3 earnings on November 06, 2018, the company saw profit per share of $1.29. That was better than the $1.17 analysts had expected. ANI Pharmaceuticals, Inc. share price started at $48.4 on the first full trading day post-earning and then exchanged hands between $55 and $55 throughout the session. The closing price of $53.52 came on the back of 118790 shares in volume.